The use and misuse of transjugular intrahepatic portasystemic shunts
- PMID: 10981005
- DOI: 10.1007/s11894-000-0053-5
The use and misuse of transjugular intrahepatic portasystemic shunts
Abstract
Transjugular intrahepatic portasystemic shunts, or TIPS, are used to create a low-resistance channel between the hepatic vein and the intrahepatic portion of the portal vein by deployment of an expandable metal stent. TIPS function like side-to-side surgical portacaval shunts, but their placement does not require anesthesia and major surgery. This article reviews the uses and misuses of TIPS in current practice. The uses include variceal hemorrhage and ascites as well as miscellaneous indications such as Budd-Chiari syndrome, veno-occlusive disease, bleeding ectopic and rectal varices, hepatic hydrothorax, and portal hypertensive gastropathy. TIPS is not indicated for primary prophylaxis of variceal hemorrhage, prehepatic portal hypertension, correction of hypersplenism and thrombocytopenia, pulmonary hypertension and hepatopulmonary syndrome, and portal hypertension associated with polycystic liver disease or Caroli's disease. Also reviewed herein is the management of patients after TIPS placement.
Similar articles
-
Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic Basics, Actual Indications and Results with Review of the Literature.Rofo. 2018 Aug;190(8):701-711. doi: 10.1055/a-0628-7347. Epub 2018 Jul 25. Rofo. 2018. PMID: 30045395 Review. English, German.
-
Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.World J Gastroenterol. 2014 Dec 7;20(45):16996-7010. doi: 10.3748/wjg.v20.i45.16996. World J Gastroenterol. 2014. PMID: 25493012 Free PMC article. Review.
-
Current use of transjugular intrahepatic portosystemic shunts.Curr Gastroenterol Rep. 2003 Feb;5(1):31-8. doi: 10.1007/s11894-003-0007-9. Curr Gastroenterol Rep. 2003. PMID: 12530946 Review.
-
The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S344-51. doi: 10.1097/MCG.0b013e318157e500. J Clin Gastroenterol. 2007. PMID: 17975487 Review.
-
The transjugular intrahepatic portosystemic shunt: an update.AJR Am J Roentgenol. 2012 Oct;199(4):746-55. doi: 10.2214/AJR.12.9101. AJR Am J Roentgenol. 2012. PMID: 22997364 Review.
Cited by
-
Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt.Gut. 2003 Jun;52(6):879-85. doi: 10.1136/gut.52.6.879. Gut. 2003. PMID: 12740346 Free PMC article.
-
Clinical efficacy of transjugular intrahepatic portosystemic shunt in the treatment of hepatopulmonary syndrome.Medicine (Baltimore). 2017 Dec;96(49):e9080. doi: 10.1097/MD.0000000000009080. Medicine (Baltimore). 2017. PMID: 29245324 Free PMC article.
-
Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis.World J Gastroenterol. 2004 Jul 1;10(13):1881-4. doi: 10.3748/wjg.v10.i13.1881. World J Gastroenterol. 2004. PMID: 15222028 Free PMC article. Clinical Trial.
-
Autoimmune thrombocytopenia in response to splenectomy in cirrhotic patients with accompanying hepatitis C.World J Gastroenterol. 2006 Feb 28;12(8):1205-10. doi: 10.3748/wjg.v12.i8.1205. World J Gastroenterol. 2006. PMID: 16534872 Free PMC article.
-
An emergency hybrid procedure that combines endoscopic treatment with partial splenic embolization for bleeding esophagogastric varices.Radiol Case Rep. 2022 Mar 19;17(5):1640-1645. doi: 10.1016/j.radcr.2022.02.041. eCollection 2022 May. Radiol Case Rep. 2022. PMID: 35342491 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Medical